Understanding any similarities between SARS and COVID-19 inflammation could help in a clinical setting. A protein in the viruses causing COVID-19 and SARS is almost identical. Researchers propose investigating whether FDA-approved ...
Jul 27, 2020
0
3
In a comprehensive study, researchers from the Rijli group found that a single Hox transcription factor expressed in a group of neurons of the pontine nucleus—the cerebral cortex most important brainstem relay to the cerebellum—determines ...
Jun 22, 2020
0
108
The United States' Defense Advanced Research Projects Agency (DARPA) has signed an Agreement worth up to $16 million over the next year with the Wyss Institute for Biologically Inspired Engineering at Harvard University to ...
Jun 16, 2020
0
1
Researchers at Tulane University School of Medicine identified a gene that causes an aggressive form of breast cancer to rapidly grow. More importantly, they have also discovered a way to "turn it off" and inhibit cancer ...
Jun 02, 2020
0
7663
(HealthDay)—For adolescent and young adult (AYA) patients with Hodgkin lymphoma (HL), treatment strategies differ, but outcomes are equivalent with treatment at pediatric and adult centers, according to a study published ...
May 29, 2020
0
2
Winter may be behind us, but do you remember the challenge of waking up on those cold, dark days? Temperature affects the behavior of nearly all living creatures, but there is still much to be learned about the link between ...
May 21, 2020
1
114
In Pennsylvania and other U.S. states, one of the keys to safely reopening society amid the COVID-19 pandemic is providing sufficient testing so that new cases of the disease do not overwhelm the public healthcare system. ...
May 12, 2020
0
5
Research has shown that chronic pain is a major health concern with ever-increasing costs. But the burden is not equal, according to a study from the University of Alabama at Birmingham. The study, published in the Journal ...
Apr 30, 2020
0
0
Several countries fighting the coronavirus outbreak are using—or debating—phone apps that trace a person's movements and who they come into contact with, allowing authorities to keep track of infections and alert people ...
Apr 28, 2020
0
2
The U.S. Food and Drug Administration (FDA) has approved Koselugo (selumetinib) for use in patients with inoperable plexiform neurofibromas, a common manifestation in the disease neurofibromatosis type one (NF1). The FDA's ...
Apr 13, 2020
0
1
